• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Trop Med Infect Dis . Clinical Features Related to Severity and Mortality among COVID-19 Patients in a Pre-Vaccine Period in Luanda, Angola

tetano

Editor, Senior Moderator
Trop Med Infect Dis


. 2022 Oct 29;7(11):338.
doi: 10.3390/tropicalmed7110338.
Clinical Features Related to Severity and Mortality among COVID-19 Patients in a Pre-Vaccine Period in Luanda, Angola


Cruz S Sebastião[SUP] 1 2 3 [/SUP], Adis Cogle[SUP] 1 4 [/SUP], Alice D'Alva Teixeira[SUP] 4 [/SUP], Ana Micolo Cândido[SUP] 2 [/SUP], Chissengo Tchoni[SUP] 1 4 [/SUP], Maria João Amorim[SUP] 5 6 [/SUP], N'gueza Loureiro[SUP] 4 [/SUP], Paolo Parimbelli[SUP] 7 [/SUP], Carlos Penha-Gonçalves[SUP] 5 [/SUP], Jocelyne Demengeot[SUP] 5 [/SUP], Euclides Sacomboio[SUP] 2 3 [/SUP], Manuela Mendes[SUP] 7 [/SUP], Margarete Arrais[SUP] 1 8 [/SUP], Joana Morais[SUP] 2 9 [/SUP], Jocelyne Neto de Vasconcelos[SUP] 1 2 [/SUP], Miguel Brito[SUP] 1 10 [/SUP]



Affiliations

Abstract

Background: Infection due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is associated with clinical features of diverse severity. Few studies investigated the severity and mortality predictors of coronavirus disease 2019 (COVID-19) in Africa. Herein, we investigated the clinical features of severity and mortality among COVID-19 patients in Luanda, Angola.
Methods: This multicenter cohort study involved 101 COVID-19 patients, between December 2020 and April 2021, with clinical and laboratory data collected. Analysis was done using independent-sample t-tests and Chi-square tests. The results were deemed significant when p < 0.05.
Results: The mean age of patients was 51 years (ranging from 18 to 80 years) and 60.4% were male. Fever (46%), cough (47%), gastrointestinal symptoms (26.7%), and asthenia (26.7%), were the most common symptoms. About 64.4% of the patients presented coexistent disorders, including hypertension (42%), diabetes (17%), and chronic renal diseases (6%). About 23% were non-severe, 77% were severe, and 10% died during hospitalization. Variations in the concentration of neutrophil, urea, creatinine, c-reactive protein, sodium, creatine kinase, and chloride were independently associated with severity and/or mortality (p < 0.05).
Conclusion: Several factors contributed to the severity and mortality among COVID-19 patients in Angola. Further studies related to clinical features should be carried out to help clinical decision-making and follow-up of COVID-19 patients in Angola.

Keywords: Angola; COVID-19; Luanda; SARS-CoV-2; clinical features.
 
Back
Top Bottom